GridAI Technologies Corp. Common Stock (GRDX) Stock Price
GRDXStock
$4.22−13.70%52W
Market Cap$30.09M
P/E—
PEG Ratio—
Div yield—
Beta1.71
GRDX Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)94.95%
Price vs S&P 500 (4W)25.44%
VGM Score58.57
GRDX Analyst Recommendations
Dec 2024
Jan 2025
Feb 2025
Mar 2025
4.00
2.17
2.17
2.17
Industry Peers — Electric & Gas Services(30)
| Symbol | Value Score | Growth Score | Momentum Score | Indicated Dividend Yield (Annual) | P/E Ratio (Annual) | Payout Ratio (TTM) | Total Debt / Equity (Quarterly) | Price |
|---|---|---|---|---|---|---|---|---|
GRDXGridAI Technologies Corp. Common Stock | — | — | C | — | — | — | 0.1x | $4.22 |
| DUKDuke Energy Corporation | C | C | B | 4.5% | 19.1x | 64.5% | 1.7x | $121.47 |
| XELXcel Energy, Inc. | C | D | C | 2.9% | 22.7x | 61.1% | 1.7x | $76.31 |
| EXCExelon Corporation | B | D | C | 3.7% | 16.2x | 60.0% | 1.8x | $43.50 |
| EDConsolidated Edison, Inc. | C | C | B | 3.6% | 20.5x | 54.8% | 1.1x | $112.26 |
| PCGPG&E Corporation | B | C | D | 1.1% | 10.7x | 13.5% | 1.9x | $13.09 |
| PEGPublic Service Enterprise Group Incorporated | C | D | D | 3.5% | 16.9x | 64.5% | 1.4x | $71.49 |
| WECWEC Energy Group, Inc. | C | D | C | 3.3% | 22.3x | 70.9% | 1.6x | $108.71 |
| AEEAmeren Corporation | C | C | B | 3.3% | 20.2x | 51.1% | 1.6x | $106.08 |
| CMSCMS Energy Corporation | C | D | C | 3.4% | 20.1x | 67.3% | 2.0x | $68.70 |
| NINiSource Inc. | C | C | C | 3.8% | 22.0x | 61.8% | 1.8x | $42.68 |
About GridAI Technologies Corp. Common Stock
GridAI Technologies Corp is a late-stage biopharmaceutical company developing non-systemic therapies for gastrointestinal diseases. Key programs include latiglutenase for celiac disease (Phase 3-ready), capeserod for gastroparesis, and adrulipase for pancreatic insufficiency. The company focuses on addressing unmet medical needs in GI health.